Collaborative research and development on mifepristone in China to reduce unwanted pregnancies and recourse to abortion.
A program proposed and executed by The Concept Foundation and funded by the Rockefeller Foundation demonstrates the feasibility of using private/public-sector collaboration for making mifepristone widely available. The application of mifepristone to emergency, luteal phase and menstrual induction contraception is being assessed in clinical research programs conducted in accordance with international standards for good clinical research. Opportunities for introduction of mifepristone in developing countries are being pursued using mifepristone produced in China in accordance with international standards of good manufacturing practice.
Duncan
G W
GW
seattll@thewcc.com
D002681:China; D003283:Contraceptives, Postcoital, Synthetic / Q000627:therapeutic use*; D003299:Cooperative Behavior; D004345:Drug Industry; D004630:Emergencies; D005193:Family Planning Services / Q000458:organization & administration*; D005260:Female; D006801:Humans; D015735:Mifepristone / Q000627:therapeutic use*; D011247:Pregnancy; D011275:Pregnancy, Unwanted; D017149:Private Sector; D016730:Program Development
D003283:Contraceptives, Postcoital, Synthetic; D015735:Mifepristone